SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Leigh C. Casadaban, Ahmad Parvinian, Jeet Minocha, Janesh Lakhoo, Christopher W. Grant, Charles E. Ray, M. Grace Knuttinen, James T. Bui, Ron C. Gaba, Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes, Digestive Diseases and Sciences, 2015, 60, 4, 1059

    CrossRef

  2. 2
    R.C. Gaba, A. Parvinian, L.C. Casadaban, P.M. Couture, S.P. Zivin, J. Lakhoo, J. Minocha, C.E. Ray, M.G. Knuttinen, J.T. Bui, Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis, Clinical Radiology, 2015, 70, 5, e51

    CrossRef

  3. 3
    Elsa Solà, Isabel Graupera, Pere Ginès, From Refractory Ascites to Dilutional Hyponatremia and Hepatorenal Syndrome: Current Options for Treatment, Current Hepatology Reports, 2014, 13, 3, 189

    CrossRef

  4. 4
    Adriano De Santis, Claudia Iegri, Loreta Kondili, Oliviero Riggio, Filippo Maria Salvatori, Carlo Catalano, Michele Di Martino, Chiara Bassanelli, Marinella Lupo, Pierleone Lucatelli, Adolfo Francesco Attili, Hepatocellular carcinoma in cirrhotic patients with transjugular intrahepatic portosystemic shunt: A retrospective case–control study, Digestive and Liver Disease, 2014, 46, 8, 726

    CrossRef

  5. 5
    Kosuke Endo, Taku Iida, Shintaro Yagi, Atsushi Yoshizawa, Yasuhiro Fujimoto, Kohei Ogawa, Yasuhiro Ogura, Akira Mori, Toshimi Kaido, Shinji Uemoto, Impact of preoperative uncontrollable hepatic hydrothorax and massive ascites in adult liver transplantation, Surgery Today, 2014, 44, 12, 2293

    CrossRef

  6. 6
    Iris W. Liou, Management of End-stage Liver Disease, Medical Clinics of North America, 2014, 98, 1, 119

    CrossRef

  7. 7
    Siddharth A. Padia, Rush H. Chewning, Matthew J. Kogut, Christopher R. Ingraham, Guy E. Johnson, Renuka Bhattacharya, Sharon W. Kwan, Wayne L. Monsky, Sandeep Vaidya, Daniel S. Hippe, Karim Valji, Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts, CardioVascular and Interventional Radiology, 2014,

    CrossRef

  8. 8
    Asha White, Outpatient Interventions for Hepatology Patients With Fluid Retention, Gastroenterology Nursing, 2014, 37, 3, 236

    CrossRef

  9. 9
    Yasuhiko Taki, Hidenori Kanazawa, Yoshiyuki Narahara, Norio Itokawa, Chisa Kondo, Takeshi Fukuda, Hirotomo Harimto, Yoko Matsushita, Hideko Kidokoro, Tamaki Katakura, Masanori Atsukawa, Yuu Kimura, Katsuhisa Nakatsuka, Choitsu Sakamoto, Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites, Hepatology Research, 2014, 44, 8
  10. 10
    Narayan Dharel, Arun J. Sanyal, Refractory Ascites: How to Establish the Diagnosis and What Can Be Done?, Current Hepatology Reports, 2014, 13, 1, 50

    CrossRef

  11. 11
    Richard Parker, Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension, Clinics in Liver Disease, 2014, 18, 2, 319

    CrossRef

  12. 12
    Kavish R. Patidar, Malcolm Sydnor, Arun J. Sanyal, Transjugular Intrahepatic Portosystemic Shunt, Clinics in Liver Disease, 2014, 18, 4, 853

    CrossRef

  13. 13
    Vicente Arroyo, A new method for therapeutic paracentesis: The automated low flow pump system. Comments in the context of the history of paracentesis, Journal of Hepatology, 2013, 58, 5, 850

    CrossRef

  14. You have free access to this content14
    Harjit K. Bhogal,, Arun J. Sanyal,, La derivación portosistémica transyugular intrahepática: Un enfoque, Clinical Liver Disease, 2013, 2, S5
  15. 15
    Martin Rössle, TIPS: 25years later, Journal of Hepatology, 2013, 59, 5, 1081

    CrossRef

  16. 16
    M. J. Parker, N. Guha, B. Stedman, N. Hacking, M. Wright, Trans-jugular intrahepatic porto-systemic shunt placement for refractory ascites: a 'real-world' UK health economic evaluation, Frontline Gastroenterology, 2013, 4, 3, 182

    CrossRef

  17. 17
    Wael E. A. Saad, Wael M. Darwish, Mark G. Davies, Sean Kumer, Curtis Anderson, David L. Waldman, Timothy Schmitt, Alan H. Matsumoto, John F. Angle, Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients: Technical Analysis and Clinical Outcome, American Journal of Roentgenology, 2013, 200, 1, 210

    CrossRef

  18. 18
    Fredric D. Gordon, Ascites, Clinics in Liver Disease, 2012, 16, 2, 285

    CrossRef

  19. 19
    Marcial Sebode, Daniel Benten, Aszites – Diagnostik, Therapie und Sekundärkomplikationen, Viszeralmedizin, 2012, 28, 2, 142

    CrossRef

  20. 20
    Alexander L. Gerbes, Veit Gülberg, Aszites, Pfortaderthrombose und hepatische Enzephalopathie bei Leberzirrhose: Aktuelle Therapieempfehlungen, Viszeralmedizin, 2012, 28, 5, 297

    CrossRef

  21. 21
    Ziad F. Gellad, Andrew J. Muir, John G. McHutchison, William Sievert, Ala I. Sharara, Kimberly A. Brown, Robert Flisiak, Ira M. Jacobson, David Kershenobich, Michael P. Manns, Kevin A. Schulman, Shelby D. Reed, Cost-Effectiveness of Truncated Therapy for Hepatitis C Based on Rapid Virologic Response, Value in Health, 2012, 15, 6, 876

    CrossRef

  22. 22
    Oliviero Riggio, Silvia Nardelli, Federica Moscucci, Chiara Pasquale, Lorenzo Ridola, Manuela Merli, Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt, Clinics in Liver Disease, 2012, 16, 1, 133

    CrossRef

  23. 23
    Florence Wong, Management of ascites in cirrhosis, Journal of Gastroenterology and Hepatology, 2012, 27, 1
  24. 24
    Shashideep Singhal, Kiran K. Baikati, Ibrahim I. Jabbour, Sury Anand, Management of Refractory Ascites, American Journal of Therapeutics, 2012, 19, 2, 121

    CrossRef

  25. 25
    Thomas Sersté, Thierry Gustot, Pierre-Emmanuel Rautou, Claire Francoz, Hassane Njimi, Francois Durand, Dominique Valla, Didier Lebrec, Richard Moreau, Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites, Journal of Hepatology, 2012, 57, 2, 274

    CrossRef

  26. 26
    Gilles Pomier-Layrargues, Louis Bouchard, Michel Lafortune, Julien Bissonnette, Dave Guérette, Pierre Perreault, The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  27. 27
    Nicholas Fidelman, Sharon W. Kwan, Jeanne M. LaBerge, Roy L. Gordon, Ernest J. Ring, Robert K. Kerlan, The Transjugular Intrahepatic Portosystemic Shunt: An Update, American Journal of Roentgenology, 2012, 199, 4, 746

    CrossRef

  28. You have free access to this content28
    Harjit K. Bhogal, Arun J. Sanyal, Transjugular intrahepatic portosystemic shunt: An overview, Clinical Liver Disease, 2012, 1, 5
  29. 29
    Asif A. Sharfuddin, Steven D. Weisbord, Paul M. Palevsky, Bruce A. Molitoris, Brenner and Rector's The Kidney, 2012,

    CrossRef

  30. 30
    Andrew King, Gail Masterton, Bridget Gunson, Simon Olliff, Doris Redhead, Kamarjit Mangat, Gabriel Oniscu, Peter Hayes, Dhiraj Tripathi, A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation, Liver Transplantation, 2011, 17, 7
  31. 31
    Hui-Hui Tan, Paul Martin, Care of the Liver Transplant Candidate, Clinics in Liver Disease, 2011, 15, 4, 779

    CrossRef

  32. 32
    Mónica Guevara, Vicente Arroyo, Hepatorenal syndrome, Expert Opinion on Pharmacotherapy, 2011, 12, 9, 1405

    CrossRef

  33. 33
    Jay Requarth, Image-Guided Palliative Care Procedures, Surgical Clinics of North America, 2011, 91, 2, 367

    CrossRef

  34. 34
    Kaushal Madan, Ashish Mehta, Management of Renal Failure and Ascites in Patients with Cirrhosis, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

  35. 35
    Sundeep J. Punamiya, Deepak N. Amarapurkar, Role of TIPS in Improving Survival of Patients with Decompensated Liver Disease, International Journal of Hepatology, 2011, 2011, 1

    CrossRef

  36. 36
    Christophe Bureau, Sophie Métivier, Mario D’Amico, Jean Marie Péron, Philippe Otal, Juan Carlos Garcia Pagan, Valérie Chabbert, Carine Chagneau-Derrode, Bogdan Procopet, Hervé Rousseau, Jaume Bosch, Jean Pierre Vinel, Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS, Journal of Hepatology, 2011, 54, 5, 901

    CrossRef

  37. 37
    Yoshiyuki Narahara, Hidenori Kanazawa, Takeshi Fukuda, Yoko Matsushita, Hirotomo Harimoto, Hideko Kidokoro, Tamaki Katakura, Masanori Atsukawa, Yasuhiko Taki, Yuu Kimura, Katsuhisa Nakatsuka, Choitsu Sakamoto, Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial, Journal of Gastroenterology, 2011, 46, 1, 78

    CrossRef

  38. 38
    Harjit K. Bhogal, Arun J. Sanyal, Using Transjugular Intrahepatic Portosystemic Shunts for Complications of Cirrhosis, Clinical Gastroenterology and Hepatology, 2011, 9, 11, 936

    CrossRef

  39. 39
    Oliviero Riggio, Lorenzo Ridola, Stefania Angeloni, Federica Cerini, Chiara Pasquale, Adolfo Francesco Attili, Fabrizio Fanelli, Manuela Merli, Filippo Maria Salvatori, Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: Results of a randomized controlled trial, Journal of Hepatology, 2010, 53, 2, 267

    CrossRef

  40. 40
    EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis, Journal of Hepatology, 2010, 53, 3, 397

    CrossRef

  41. 41
    Oliviero Riggio, Lorenzo Ridola, Cristina Lucidi, Stefania Angeloni, Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: Time to update the guidelines?, Digestive and Liver Disease, 2010, 42, 7, 462

    CrossRef

  42. You have free access to this content42
    Xingjiang Wu, Weiwei Ding, Jianmin Cao, Jianmin Han, Qian Huang, Ning Li, Jieshou Li, Favorable clinical outcome using a covered stent following transjugular intrahepatic portosystemic shunt in patients with portal hypertension, Journal of Hepato-Biliary-Pancreatic Sciences, 2010, 17, 5
  43. 43
    Preeti A. Reshamwala, Management of Ascites, Critical Care Nursing Clinics of North America, 2010, 22, 3, 309

    CrossRef

  44. 44
    Francesco Salerno, Massimo Cazzaniga, Silvia Accordino, May vaptans contribute to the treatment of refractory ascites?, Journal of Hepatology, 2010, 53, 2, 225

    CrossRef

  45. 45
    Francesco Salerno, Monica Guevara, Mauro Bernardi, Richard Moreau, Florence Wong, Paolo Angeli, Guadalupe Garcia-Tsao, Samuel S. Lee, Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis, Liver International, 2010, 30, 7
  46. 46
    Ulrich Thalheimer, Andrew K. Burroughs, Reply to the letter by S. Montagnese et al. regarding "TIPS for refractory ascites", Journal of Gastroenterology, 2010, 45, 3, 344

    CrossRef

  47. 47
    Wael E.A. Saad, Wael M. Darwish, Mark G. Davies, David L. Waldman, Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients for Management of Refractory Ascites: Clinical Outcome, Journal of Vascular and Interventional Radiology, 2010, 21, 2, 218

    CrossRef

  48. 48
    Bruce A. Runyon, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  49. 49
    Doris Duller, Daniela Kniepeiss, Carolin Lackner, Rupert H. Portugaller, Estrella Jakoby, Silvia Schaffellner, Philipp Stiegler, Kahn Judith, Helmut Mueller, Regina Roller, Karl Heinz Tscheliessnigg, Florian Iberer, Biliary obstruction as a complication of transjugular intrahepatic portosystemic shunt, Liver Transplantation, 2009, 15, 5
  50. 50
    Bruce A. Runyon, Management of adult patients with ascites due to cirrhosis: An update, Hepatology, 2009, 49, 6
  51. 51
    Fedja A. Rochling, Rowen K. Zetterman, Management of Ascites, Drugs, 2009, 69, 13, 1739

    CrossRef

  52. 52
    Ulrich Thalheimer, Gioacchino Leandro, Dimitrios N. Samonakis, Christos K. Triantos, Marco Senzolo, Konrad Fung, Neil Davies, David Patch, Andrew K. Burroughs, TIPS for refractory ascites: a single-centre experience, Journal of Gastroenterology, 2009, 44, 10, 1089

    CrossRef

  53. 53
    Édouard Bardou-Jacquet, Richard Lorho, Transplantation hépatique : qui peut en bénéficier et quand doit-on l’envisager ?, La Presse Médicale, 2009, 38, 9, 1258

    CrossRef

  54. 54
    F. Durand, Ascite réfractaire : place de la transplantation hépatique, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 721

    CrossRef

  55. 55
    Jen-Jung Pan, Chaoru Chen, James G. Caridi, Brian Geller, Roberto Firpi, Victor I. Machicao, Irvin F. Hawkins, Consuelo Soldevila-Pico, David R. Nelson, Giuseppe Morelli, Factors Predicting Survival after Transjugular Intrahepatic Portosystemic Shunt Creation: 15 Years' Experience from a Single Tertiary Medical Center, Journal of Vascular and Interventional Radiology, 2008, 19, 11, 1576

    CrossRef

  56. 56
    Oliviero Riggio, Stefania Angeloni, Filippo Maria Salvatori, Adriano De Santis, Federica Cerini, Alessio Farcomeni, Adolfo Francesco Attili, Manuela Merli, Incidence, Natural History, and Risk Factors of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt With Polytetrafluoroethylene-Covered Stent Grafts, The American Journal of Gastroenterology, 2008, 103, 11, 2738

    CrossRef

  57. 57
    C. Ripoll Noiseux, R. Baares Caizares, Indicaciones de la derivaci?n portosist?mica percut?nea intrahep?tica, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2008, 10, 11, 746

    CrossRef

  58. 58
    Timothy Clark, Introduction, Techniques in Vascular and Interventional Radiology, 2008, 11, 4, 201

    CrossRef

  59. 59
    J.-J. Pan, C. Chen, B. Geller, R. Firpi, V.I. Machicao, J.G. Caridi, D.R. Nelson, G. Morelli, Is sonographic surveillance of polytetrafluoroethylene-covered transjugular intrahepatic portosystemic shunts (TIPS) necessary? A single centre experience comparing both types of stents, Clinical Radiology, 2008, 63, 10, 1142

    CrossRef

  60. 60
    Gaurav Arora, Emmet B. Keeffe, Management of Chronic Liver Failure Until Liver Transplantation, Medical Clinics of North America, 2008, 92, 4, 839

    CrossRef

  61. 61
    Paolo Angeli, Carlo Merkel, Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis, Journal of Hepatology, 2008, 48, S93

    CrossRef

  62. 62
    R. Moreau, D. Lebrec, Prise en charge de l’ascite réfractaire à l’exclusion de l’anastomose portosystémique intrahépatique et de la transplantation hépatique, Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 710

    CrossRef

  63. 63
    D. Lebrec, R. Moreau, Prise en charge de l’ascite réfractaire par l’anastomose portosystémique intrahépatique (TIPS), Gastroentérologie Clinique et Biologique, 2008, 32, 8-9, 717

    CrossRef

  64. 64
    Gianni Biancofiore, Connie L Davis, Renal dysfunction in the perioperative liver transplant period, Current Opinion in Organ Transplantation, 2008, 13, 3, 291

    CrossRef

  65. 65
    Andrés Cárdenas, Pere Ginès, What’s new in the treatment of ascites and spontaneous bacterial peritonitis, Current Gastroenterology Reports, 2008, 10, 1, 7

    CrossRef

  66. 66
    Ralph F. Lee, Tamara K. Glenn, Samuel S. Lee, Cardiac dysfunction in cirrhosis, Best Practice & Research Clinical Gastroenterology, 2007, 21, 1, 125

    CrossRef

  67. 67
    Vanessa Stadlbauer, Josef Tauss, Horst R. Portugaller, Philipp Stiegler, Florian Iberer, Rudolf E. Stauber, Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): Management with l-ornithine-l-aspartate and stent reduction, Metabolic Brain Disease, 2007, 22, 1, 45

    CrossRef

  68. 68
    Andrés Cárdenas, Vicente Arroyo, Management of ascites and hepatic hydrothorax, Best Practice & Research Clinical Gastroenterology, 2007, 21, 1, 55

    CrossRef

  69. 69
    Jean-Marie Péron, Christophe Bureau, Jean-Pierre Vinel, Place du TIPS dans le traitement de l’ascite réfractaire, Gastroentérologie Clinique et Biologique, 2007, 31, 3, 341

    CrossRef

  70. 70
    Priya Grewal, Paul Martin, Pretransplant Management of the Cirrhotic Patient, Clinics in Liver Disease, 2007, 11, 2, 431

    CrossRef

  71. 71
    J. J. KUIPER, R. A. DE MAN, H. R. VAN BUUREN, Review article: management of ascites and associated complications in patients with cirrhosis, Alimentary Pharmacology & Therapeutics, 2007, 26,
  72. 72
    Patrick S. Kamath, W. Ray Kim, The model for end-stage liver disease (MELD), Hepatology, 2007, 45, 3
  73. 73
    Alexander L. Gerbes, The patient with refractory ascites, Best Practice & Research Clinical Gastroenterology, 2007, 21, 3, 551

    CrossRef

  74. 74
    Luis Colombato, The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension, Journal of Clinical Gastroenterology, 2007, 41, Supplement 3, S344

    CrossRef

  75. 75
    M. Senzolo, P. Burra, E. Cholongitas, F. Lodato, L. Marelli, P. Manousou, D. Patch, G.C. Sturniolo, A.K. Burroughs, The transjugular route: The key hole to the liver world, Digestive and Liver Disease, 2007, 39, 2, 105

    CrossRef

  76. 76
    Francesco Salerno, Calogero Cammà, Marco Enea, Martin Rössle, Florence Wong, Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-analysis of Individual Patient Data, Gastroenterology, 2007, 133, 3, 825

    CrossRef

  77. 77
    A.M. SMITH, J.M. HENDERSON, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  78. 78
    J.P. AHLUWALIA, D.R. LABRECQUE, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  79. 79
    Elizabeth E. Culler, Lennart E. Lögdberg, Blood Banking and Transfusion Medicine, 2007,

    CrossRef

  80. 80
    S.J. KNECHTLE, L.F. RIKKERS, Surgery of the Liver, Biliary Tract and Pancreas, 2007,

    CrossRef

  81. 81
    M. Pozzi, L. Ratti, E. Redaelli, C. Guidi, G. Mancia, Cardiovascular abnormalities in special conditions of advanced cirrhosis.The circulatory adaptative changes to specific therapeutic procedures for the management of refractory ascites, Gastroenterología y Hepatología, 2006, 29, 4, 263

    CrossRef

  82. 82
    Alexandre Pariente, Décompensation ascitique, Gastroentérologie Clinique et Biologique, 2006, 30, 6-7, 870

    CrossRef

  83. 83
    Ramon Planas, Silvia Montoliu, Belen Ballesté, Monica Rivera, Mireia Miquel, Helena Masnou, Jose Antonio Galeras, María D. Giménez, Justiniano Santos, Isabel Cirera, Rosa María Morillas, Susanna Coll, Ricard Solà, Natural History of Patients Hospitalized for Management of Cirrhotic Ascites, Clinical Gastroenterology and Hepatology, 2006, 4, 11, 1385

    CrossRef

  84. 84
    Maxim Itkin, Scott O. Trerotola, S. William Stavropoulos, Aalpen Patel, Jeffrey I. Mondschein, Michael C. Soulen, Catherine M. Tuite, Richard D. Shlansky-Goldberg, Thomas W. Faust, K. Rajender Reddy, Jeffrey A. Solomon, Timothy W.I. Clark, Portal Flow and Arterioportal Shunting after Transjugular Intrahepatic Portosystemic Shunt Creation, Journal of Vascular and Interventional Radiology, 2006, 17, 1, 55

    CrossRef

  85. 85
    Paul Harrod-Kim, Wael Saad, David Waldman, Predictors of Early Mortality after Transjugular Intrahepatic Portosystemic Shunt Creation for the Treatment of Refractory Ascites, Journal of Vascular and Interventional Radiology, 2006, 17, 10, 1605

    CrossRef

  86. 86
    George Therapondos, Lieke Hol, Fabiana Benjaminov, Florence Wong, The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis, Hepatology, 2006, 44, 3
  87. 87
    Guadalupe Garcia-Tsao, The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites, Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3, 7, 380

    CrossRef

  88. 88
    Seyed A Gaskari, Hooman Honar, Samuel S Lee, Therapy Insight: cirrhotic cardiomyopathy, Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3, 6, 329

    CrossRef

  89. 89
    Marco Senzolo, Evangelos Cholongitas, Jonathan Tibballs, Andrew Burroughs, David Patch, Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome, European Journal of Gastroenterology & Hepatology, 2006, 1143

    CrossRef

  90. 90
    Jeanne M. LaBerge, Transjugular Intrahepatic Portosystemic Shunt—Role in Treating Intractable Variceal Bleeding, Ascites, and Hepatic Hydrothorax, Clinics in Liver Disease, 2006, 10, 3, 583

    CrossRef

  91. 91
    Pierre Deltenre, Didier Lebrec, Philippe Mathurin, Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites, Gastroenterology, 2006, 130, 4, 1372

    CrossRef

  92. 92
    Agustín Albillos, Rafael Bañares, Mónica González, María-Vega Catalina, Luis-Miguel Molinero, A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites, Journal of Hepatology, 2005, 43, 6, 990

    CrossRef

  93. 93
    Paul Harrod-Kim, David L. Waldman, Abnormal Portal Venous Flow at Sonography Predicts Reduced Survival after Transjugular Intrahepatic Portosystemic Shunt Creation, Journal of Vascular and Interventional Radiology, 2005, 16, 11, 1459

    CrossRef

  94. 94
    Thomas D. Boyer, Ziv J. Haskal, American Association for the Study of Liver Diseases Practice Guidelines: The Role of Transjugular Intrahepatic Portosystemic Shunt Creation in the Management of Portal Hypertension, Journal of Vascular and Interventional Radiology, 2005, 16, 5, 615

    CrossRef

  95. 95
    Alexander L. Gerbes, Veit Gülberg, Benefit of TIPS for patients with refractory or recidivant ascites: Serum bilirubin may make the difference, Hepatology, 2005, 41, 1
  96. 96
    Andres Cardenas, Pere Ginès, Management of complications of cirrhosis in patients awaiting liver transplantation, Journal of Hepatology, 2005, 42, 1, S124

    CrossRef

  97. 97
    Pratima Sharma, Jorge Rakela, Management of pre–liver transplantation patient—Part 2, Liver Transplantation, 2005, 11, 3
  98. 98
    O. Riggio, A. Masini, C. Efrati, F. Nicolao, S. Angeloni, Filippo M. Salvatori, M. Bezzi, Adolfo F. Attili, M. Merli, Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study, Journal of Hepatology, 2005, 42, 5, 674

    CrossRef

  99. 99
    Guadalupe Garcia-Tsao, Portal hypertension, Current Opinion in Gastroenterology, 2005, 21, 3, 313

    CrossRef

  100. 100
    Mical S. Campbell, Colleen M. Brensinger, Arun J. Sanyal, Chris Gennings, Florence Wong, Kris V. Kowdley, Timothy McCashland, K. Rajender Reddy, Quality of life in refractory ascites: Transjugular intrahepatic portal-systemic shunting versus medical therapy, Hepatology, 2005, 42, 3
  101. 101
    Andrés Cárdenas, Vicente Arroyo, Refractory Ascites, Digestive Diseases, 2005, 23, 1, 30

    CrossRef

  102. 102
    E. CHOLONGITAS, G. V. PAPATHEODORIDIS, M. VANGELI, N. TERRENI, D. PATCH, A. K. BURROUGHS, Systematic review: the model for end-stage liver disease – should it replace Child-Pugh's classification for assessing prognosis in cirrhosis?, Alimentary Pharmacology & Therapeutics, 2005, 22, 11-12
  103. 103
    Thomas D. Boyer, Ziv J. Haskal, The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension, Hepatology, 2005, 41, 2
  104. 104
    Andreas Ochs, Transjugular Intrahepatic Portosystemic Shunt, Digestive Diseases, 2005, 23, 1, 56

    CrossRef

  105. 105
    P. Deltenre, P. Mathurin, S. Dharancy, R. Moreau, P. Bulois, J. Henrion, F. R. Pruvot, O. Ernst, J. C. Paris, D. Lebrec, Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta-analysis, Liver International, 2005, 25, 2
  106. 106
    Gennaro D’Amico, Angelo Luca, Alberto Morabito, Roberto Miraglia, Mario D’amico, Uncovered Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites: A Meta-Analysis, Gastroenterology, 2005, 129, 4, 1282

    CrossRef

  107. 107
    Francesco Salerno, Massimo Cazzaniga, TIPS versus paracentesis for the treatment of refractory ascites, Hepatology, 2004, 40, 6
  108. 108
    Albert Lau, Curt Bay, Abdul Nadir, TIPS versus paracentesis for the treatment of refractory ascites, Hepatology, 2004, 40, 6
  109. 109
    Andrés Cárdenas, Isabel Graupera, Pere Ginès, Ascites,
  110. 110
    Andrés Cárdenas, Pere Ginès, Ascites and hepatorenal syndrome,
  111. 111
    Pere Ginès, Andrés Cárdenas, Vicente Arroyo, Juan Rodés, Ascites, Hepatorenal Syndrome and Spontaneous Bacterial Peritonitis,
  112. 112
    Yosef Golowa, Jacob Cynamon, Endovascular Treatment of Portal Hypertension,
  113. 113
    Sammy Saab, Jose M Nieto, Shannon K Lewis, Bruce A Runyon, TIPS versus paracentesis for cirrhotic patients with refractory ascites, The Cochrane Library,